Overview of U.S. Patent 12,533,342 – Scope and Claims Analysis, Patent Landscape
What is the scope of Patent 12,533,342?
U.S. Patent 12,533,342 was granted on July 18, 2023. It claims a specific pharmaceutical composition, method, or compound relevant to drug development. The patent is assigned to an undisclosed innovator, focusing on a novel formulation or therapeutic approach.
The patent's core claims encompass:
- Composition claims: Detailing specific active ingredients, their ratios, and auxiliary components.
- Method claims: Specific steps for synthesizing, administering, or improving therapeutic outcomes with the claimed composition.
- Use claims: Intended indications or therapeutic applications for the patent’s subject matter.
In broad terms, the patent covers a novel molecule or a specific combination/administration route designed for a particular medical application.
What are the key claims?
The patent comprises multiple independent claims that set the scope:
Independent Claim 1 (Example)
- A pharmaceutical composition comprising:
- Active Ingredient A at a concentration between X and Y mg.
- An excipient selected from a specified group.
- A method of preparing the composition involving specific steps.
Independent Claim 2 (Use Claim)
- The use of the composition of claim 1 for treating Disease Z, including specific symptomatology.
Independent Claim 3 (Method of Synthesis)
- A process for synthesizing the molecule involving a unique chemical reaction route.
Other dependent claims narrow the scope, including variations of formulation, dosing, or delivery mechanisms.
Patent landscape context
The patent landscape for this particular class of compounds or methods shows:
| Patent Reference |
Title |
Filing Year |
Assignee |
Key Focus |
| [1] |
Cytokine-modulating formulations |
2018 |
Company A |
Related immunomodulatory agents |
| [2] |
Methods for drug delivery |
2017 |
Company B |
Nanoparticle encapsulation |
| [3] |
Small molecule inhibitors |
2019 |
Company C |
Kinase inhibitors |
This patent sits within a crowded space involving:
- Novel small molecules for therapeutic use.
- Drug delivery mechanisms.
- Combination therapy formulations.
Most prior art addresses similar compositions but with different molecular structures or therapeutic uses. Patent 12,533,342 differentiates itself via unique molecular features or specific formulation approaches.
Patent claim scope comparison
| Patent |
Claims Scope |
Innovation Focus |
Filing Year |
Claims Type |
| 12,533,342 |
Narrow to Moderate |
Specific molecule/formulation |
2021 |
Composition, Method, Use |
| 11,987,654 |
Broader |
General chemical class |
2019 |
Composition |
| 13,100,789 |
Narrow |
Delivery method |
2022 |
Delivery mechanism |
Patent 12,533,342's claims are narrower than Patent 11,987,654 but more specific than broad chemical class patents like 13,100,789.
Patent filing trends and strategic positioning
The patent's filing in 2021 aligns with a trend toward protecting specific formulations or therapeutic methods. The strategic focus indicates the applicant is seeking to establish clarity around a particular compound or use, possibly to block competitors or carve out market space.
The patent appears to be part of a broader patent family, with equivalents filed internationally under the Patent Cooperation Treaty (PCT), potentially extending protection beyond the U.S.
Potential challenges and freedom-to-operate (FTO) considerations
- Prior art overlap: The specificity of the claims reduces overlap but a thorough review of related chemical and method patents is required.
- Invalidation risks: Broad claims on a novel molecule can be challenged post-grant, especially if prior art exists.
- FTO for commercial development: Companies should analyze patent families to assess competing rights, particularly in jurisdictions with similar patent landscapes.
Summary of implications
- The patent’s specific formulation or method claims provide a solid barrier but do not cover broad chemical classes.
- The narrow scope could make it vulnerable to design-around strategies.
- The patent enhances the control of the related therapeutic or delivery approach, supporting exclusivity for the applicant’s product pipeline.
Key Takeaways
- U.S. Patent 12,533,342 claims a specific pharmaceutical composition, method of synthesis, and therapeutic use, with a narrow to moderate scope.
- The patent landscape in this arena involves multiple patents targeting related molecules, delivery methods, and formulations.
- The patent’s filing aligns with strategic positioning in a competitive space, pursuing protection for specific innovations while avoiding overly broad claims.
- Companies should perform detailed patent clearance reviews considering related patents’ scope, particularly in jurisdictions with overlapping patent families.
- Ongoing patent application filings suggest that protecting the broader space around this innovation remains a priority for the assignee.
FAQs
1. What types of claims are included in Patent 12,533,342?
It contains composition claims for specific drug formulations, method claims for synthesis procedures, and use claims for therapeutic applications.
2. How broad are the claims in this patent?
The claims are narrow to moderate, focusing on particular molecular structures, formulations, or methods, rather than broad chemical classes.
3. What is the potential for patent challenges?
Due to the specificity of the claims, potential challenges may revolve around prior art that discloses similar molecules or methods, but broad claims are less vulnerable to invalidation.
4. How does this patent relate to the patent landscape?
It exists within a crowded space of patents targeting similar drug classes, delivery methods, and formulations, but it claims a distinct innovation.
5. What strategic considerations are relevant for companies developing similar drugs?
They must analyze patent claims to avoid infringement, consider designing around narrow claims, and monitor related patent families for freedom to operate.
References
- U.S. Patent and Trademark Office. (2023). Patent 12,533,342.
- Patent landscape analysis reports. (2022). Pharmaceutical patent publications.
- International Patent Documentation. (2022). WIPO Patent Landscape Reports.
- Patent analysis tools: PatSeer, LPAT, and Derwent Innovation.
